{"title":"Atrial contractile function and fibrosis in patients with paroxysmal atrial fibrillation in sinus rhythm","authors":"Ashikhmin Yaroslav, Drapkina Oxana","doi":"10.24875/acme.m22000347","DOIUrl":"https://doi.org/10.24875/acme.m22000347","url":null,"abstract":"","PeriodicalId":475954,"journal":{"name":"Archivos de cardiolog�a de M�xico (English ed Internet)","volume":"70 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136117224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Héctor M. Jiménez-Vargas, Emilia J. Patiño-Bahena, Juan Calderón-Colmenero, José A. García-Montes
{"title":"Is there a total anomalous connection of pulmonary veins with hypoplastic right ventricle?","authors":"Héctor M. Jiménez-Vargas, Emilia J. Patiño-Bahena, Juan Calderón-Colmenero, José A. García-Montes","doi":"10.24875/acme.m22000359","DOIUrl":"https://doi.org/10.24875/acme.m22000359","url":null,"abstract":"","PeriodicalId":475954,"journal":{"name":"Archivos de cardiolog�a de M�xico (English ed Internet)","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136117221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
José A. Citalán-Jiménez, Jorge A. Lara-Vargas, Juan A. Pineda-Juárez, María C. Salgado-Solorio, Marco A. Reza-Orozco, Rodolfo Arteaga, Jesica Vergara-Guzmán, Rodrigo Contreras-Juvenal, María Galván-López, Eduardo A. Leyva-Valadez
{"title":"Myocardial efficiency index in patients with heart disease after a cardiac rehabilitation program","authors":"José A. Citalán-Jiménez, Jorge A. Lara-Vargas, Juan A. Pineda-Juárez, María C. Salgado-Solorio, Marco A. Reza-Orozco, Rodolfo Arteaga, Jesica Vergara-Guzmán, Rodrigo Contreras-Juvenal, María Galván-López, Eduardo A. Leyva-Valadez","doi":"10.24875/acme.m22000349","DOIUrl":"https://doi.org/10.24875/acme.m22000349","url":null,"abstract":"","PeriodicalId":475954,"journal":{"name":"Archivos de cardiolog�a de M�xico (English ed Internet)","volume":"244 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136117225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marcio Concepción-Zavaleta, Juan Muñoz-Moreno, María Quispe-Flores, Luciana Rafael-Robles, Carlos Lobato-Jeri, Anthony Ramos-Yataco, Luis Concepción-Urteaga, José Paz-Ibarra
Acromegaly is a rare disease, mainly caused by a pituitary tumor secreting growth hormone. It is characterized by slow progression and is associated with a multisystemic involvement, being the cardiovascular system, one of the most involved, even reaching, more than 10 years ago, to represent the main cause of death. Cardiovascular complications develop as a result of elevated blood concentrations of growth hormone and insulin-like growth factor 1, which exert direct and indirect effects on the endothelium, large vessels, kidney and cardiomyocytes; causing arterial hypertension, valve disease, cardiac arrhythmia and a specific heart disease called acromegalic cardiomyopathy. After the literature overview related to the pathophysiology, clinical manifestations, diagnosis and treatment of cardiovascular involvement, we found that from a cardiovascular point of view, patients with acromegaly can range from an asymptomatic state to severe cardiac dysfunction, being the biochemical markers and imaging studies diagnostic tools that allow assessment the degree of cardiovascular disease in order to provide individualized treatment. The normalization of growth hormone and insulin-like growth factor 1 levels improves cardiovascular parameters, and therefore its prognosis.La acromegalia es una enfermedad rara, causada principalmente por un tumor hipofisiario secretor de hormona de crecimiento (GH), se caracteriza por tener progresión lenta y asociarse a un compromiso multisistémico, siendo el aparato cardiovascular uno de los más comprometidos, llegando, incluso, desde hace más de 10 años a representar la principal causa de muerte. Las complicaciones cardiovasculares se desarrollan como resultado de las concentraciones sanguíneas elevadas de la GH y del factor de crecimiento similar a la insulina tipo 1 (IGF-1), los cuales ejercen efectos directos e indirectos sobre el endotelio, grandes vasos, riñón y los cardiomiocitos; produciendo hipertensión arterial, enfermedad valvular, arritmia cardiaca y una cardiopatía propia de la acromegalia denominada miocardiopatía acromegálica. Luego de la revisión bibliográfica actualizada relacionada con la fisiopatología, manifestaciones clínicas, diagnóstico y tratamiento del compromiso cardiovascular, encontramos que desde el punto de vista cardiovascular los pacientes con acromegalia pueden variar desde un estado asintomático hasta presentar disfunción cardiaca severa, siendo los marcadores bioquímicos y exámenes de imagen herramientas diagnósticas que permiten evaluar el grado de afección cardiovascular para poder brindar un tratamiento individualizado. La normalización de los valores de la GH y del IGF-1 mejora los parámetros cardiovasculares y, por tanto, su pronóstico.
肢端肥大症是一种罕见的疾病，主要由垂体肿瘤分泌生长激素引起。它的特点是进展缓慢，并与多系统受累有关，其中心血管系统是受累最严重的系统之一，甚至在10多年前就已成为主要死亡原因。心血管并发症是由于血液中生长激素和胰岛素样生长因子1的浓度升高而产生的，它们对内皮、大血管、肾脏和心肌细胞产生直接和间接的影响;导致动脉高血压，瓣膜疾病，心律失常和一种特殊的心脏病叫做肢端肥大性心肌病。通过对累及心血管的病理生理、临床表现、诊疗等相关文献的综述，我们发现，从心血管角度来看，肢端肥大症患者可以从无症状状态到严重心功能障碍，是评估心血管疾病程度的生化指标和影像学研究诊断工具，从而提供个体化治疗。生长激素和胰岛素样生长因子1水平的正常化可改善心血管参数，从而改善其预后。肢端肥大症是一种主要的恶性肿瘤，主要的原因是肿瘤的恶性肿瘤，激素分泌的恶性肿瘤(GH)，主要的特征是肿瘤的恶性肿瘤progresión是一种多器官的恶性肿瘤，主要的原因是心血管的恶性肿瘤más是一种主要的恶性肿瘤，包括恶性肿瘤más de 10 años是主要的恶性肿瘤。拉斯维加斯造成心血管se desarrollan科莫resultado de Las concentraciones sanguineas分类de la GH y de crecimiento del因素相似的la insulina蒂波1 (igf - 1),洛杉矶哪种ejercen对导演e indirectos尤其el endotelio,外面是rinon y洛cardiomiocitos;产癌hipertensión动脉性，心瓣膜内膜性，心绞痛，心脏病和心脏病cardiopatía肢端肥大异位miocardiopatía acromegálica。Luego de la revisión bibliográfica actualizada relatisionada con la fisiopatología, manifestaciones clínicas, diagnóstico y travamiento del concaco cardiovascular, encontramos que que del punto de vista心血管疾病患者合并肢端肥大症(不同的de estado asintomático hasta presentar disfunción cardiaca severa)，链接:链接:链接:链接:exámenes链接:链接:链接:exámenes链接:链接:链接:链接:链接:链接:链接:链接:链接:链接:链接:链接:链接:链接:链接:链接:链接:La normalización de los valores de La GH y del IGF-1 mejora los parámetros心血管y, por tanto, su pronóstico。
{"title":"Cardiovascular complications associated with acromegaly. A state-of-the-art","authors":"Marcio Concepción-Zavaleta, Juan Muñoz-Moreno, María Quispe-Flores, Luciana Rafael-Robles, Carlos Lobato-Jeri, Anthony Ramos-Yataco, Luis Concepción-Urteaga, José Paz-Ibarra","doi":"10.24875/acme.m22000357","DOIUrl":"https://doi.org/10.24875/acme.m22000357","url":null,"abstract":"Acromegaly is a rare disease, mainly caused by a pituitary tumor secreting growth hormone. It is characterized by slow progression and is associated with a multisystemic involvement, being the cardiovascular system, one of the most involved, even reaching, more than 10 years ago, to represent the main cause of death. Cardiovascular complications develop as a result of elevated blood concentrations of growth hormone and insulin-like growth factor 1, which exert direct and indirect effects on the endothelium, large vessels, kidney and cardiomyocytes; causing arterial hypertension, valve disease, cardiac arrhythmia and a specific heart disease called acromegalic cardiomyopathy. After the literature overview related to the pathophysiology, clinical manifestations, diagnosis and treatment of cardiovascular involvement, we found that from a cardiovascular point of view, patients with acromegaly can range from an asymptomatic state to severe cardiac dysfunction, being the biochemical markers and imaging studies diagnostic tools that allow assessment the degree of cardiovascular disease in order to provide individualized treatment. The normalization of growth hormone and insulin-like growth factor 1 levels improves cardiovascular parameters, and therefore its prognosis.La acromegalia es una enfermedad rara, causada principalmente por un tumor hipofisiario secretor de hormona de crecimiento (GH), se caracteriza por tener progresión lenta y asociarse a un compromiso multisistémico, siendo el aparato cardiovascular uno de los más comprometidos, llegando, incluso, desde hace más de 10 años a representar la principal causa de muerte. Las complicaciones cardiovasculares se desarrollan como resultado de las concentraciones sanguíneas elevadas de la GH y del factor de crecimiento similar a la insulina tipo 1 (IGF-1), los cuales ejercen efectos directos e indirectos sobre el endotelio, grandes vasos, riñón y los cardiomiocitos; produciendo hipertensión arterial, enfermedad valvular, arritmia cardiaca y una cardiopatía propia de la acromegalia denominada miocardiopatía acromegálica. Luego de la revisión bibliográfica actualizada relacionada con la fisiopatología, manifestaciones clínicas, diagnóstico y tratamiento del compromiso cardiovascular, encontramos que desde el punto de vista cardiovascular los pacientes con acromegalia pueden variar desde un estado asintomático hasta presentar disfunción cardiaca severa, siendo los marcadores bioquímicos y exámenes de imagen herramientas diagnósticas que permiten evaluar el grado de afección cardiovascular para poder brindar un tratamiento individualizado. La normalización de los valores de la GH y del IGF-1 mejora los parámetros cardiovasculares y, por tanto, su pronóstico.","PeriodicalId":475954,"journal":{"name":"Archivos de cardiolog�a de M�xico (English ed Internet)","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136117437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diagnostic utility of 31 ECG criteria for predicting echocardiographic left ventricular geometry","authors":"Fernando De-la-Garza-Salazar","doi":"10.24875/acme.m22000355","DOIUrl":"https://doi.org/10.24875/acme.m22000355","url":null,"abstract":"","PeriodicalId":475954,"journal":{"name":"Archivos de cardiolog�a de M�xico (English ed Internet)","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136117216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Luis-Efrén Santos-Martínez, Sergio G. Olmos-Temois, Ángel Ramos-Enríquez, Eduardo A. González-Escudero, Luis A. Baeza-Herrera, María A. López-Polanco, Luis A. Cota-Apodaca, Francisco J. González-Ruiz, Efrén Melano-Carranza, Gustavo Rojas-Velasco
{"title":"Venous-arterial oxygen saturation and serum lactate in the postoperative period of cardiac surgery","authors":"Luis-Efrén Santos-Martínez, Sergio G. Olmos-Temois, Ángel Ramos-Enríquez, Eduardo A. González-Escudero, Luis A. Baeza-Herrera, María A. López-Polanco, Luis A. Cota-Apodaca, Francisco J. González-Ruiz, Efrén Melano-Carranza, Gustavo Rojas-Velasco","doi":"10.24875/acme.m22000352","DOIUrl":"https://doi.org/10.24875/acme.m22000352","url":null,"abstract":"","PeriodicalId":475954,"journal":{"name":"Archivos de cardiolog�a de M�xico (English ed Internet)","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136117218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：